FOLD- Amicus Therapeutics, Inc.

Name: Amicus Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Amicus Therapeutics, Inc. (FOLD) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Campbell Bradley L	1.02M	$14.80M	-
Other	Rosenberg Ellen	464.6K	$6.73M	-
Other	Castelli Jeff	409.3K	$5.93M	-
Other	Clark David Michael	221.8K	$3.21M	-
CFO	Harford Simon N.R.	143.6K	$2.08M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 19, 2025	Clark David Michael64	Chief People Officer	Sell	25,642	$14.17	$363,380.47	-9.5%	+1.4%	-
Dec 15, 2025	Campbell Bradley L66	President And CEO	Sale+OE	77,926	$10.86	$846,011.41	-6.5%	+32.1%	-
Dec 15, 2025	Clark David Michael64	Chief People Officer	Sell	25,643	$11.00	$282,073.00	-8.6%	+32.1%	-
Dec 1, 2025	Campbell Bradley L66	President And CEO	Sale+OE	14,587	$10.01	$146,011.49	-1.3%	+46.6%	-
Nov 26, 2025	Rosenberg Ellen65	Chief Legal Officer	Sale+OE	95,621	$10.02	$958,478.00	-5.9%	+43.3%	-
Nov 24, 2025	Castelli Jeff67	Chief Development Officer	Sale+OE	76,158	$10.16	$773,658.66	-14.8%	+45.1%	-
Nov 24, 2025	Clark David Michael64	Chief People Officer	Sell	25,643	$10.10	$258,932.76	-7.9%	+45.1%	-
Nov 24, 2025	Campbell Bradley L66	President And CEO	Sale+OE	14,587	$10.04	$146,522.04	-1.3%	+45.1%	-
Nov 4, 2025	Clark David Michael64	Chief People Officer	Sell	25,643	$9.51	$243,859.80	-7.4%	+59.0%	-
Feb 19, 2025	Campbell Bradley L66	President And CEO	Sale+OE	400	$10.00	$4,000.00	-	-31.1%	+50.1%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC